INSTRUCTION: ANGIO-1

ANGIOstream Kit™

Description

Angiogenesis—the formation of new blood vessels from existing vasculature—is an integral component of both normal and pathological processes. Endothelial cells represent the key cell type involved in this
process. During angiogenesis, these cells disrupt the surrounding basement membrane and migrate toward an angiogenic stimulus, where they proliferate and re-organize to form the necessary threedimensional vessel structures. The Angiogenesis Kit contains media and reagents that have been optimized for the culturing of Human Umbilical Vein Endothelial Cells (HUVECs) onto plate containing a thin layer of the small mobile stem cell-derived extracellular matrix (SMS-ECM-1). The kit has been optimized for the formation of both endothelial cell-derived micro-vessels and suspended macro-vessels that can be easily monitored. The following protocol provides instructions for performing this groundbreaking assay.

*Only 20 wells are coated, **Shelf life may vary based on date of manufacturing

Not provided but required: Antibiotics (recommended: 10 µl Gentamicin & 0.25 µg/ml Amphotericin B)

Product use

Protected under U.S. Pat. No. 10041037B2; all SMSbiotech, Inc. products are to be used for research purposes only, and for no other purpose. The phrase research purposes only means scientific research
programs directly under the user’s control, which are specifically directed to the purposes of internal research and not for any Commercial Purpose.

Important information

• Store S-25 (50X) Large Vessel Endothelial Supplement in a non-frost-free freezer. Avoid multiple freeze/thaw cycles.
• Do not freeze M-25 Medium.
• Store plates coated with SMS-ECM-1 in the refrigerator (4-7°C) in intact, vacuum-sealed plastic bags until ready for use.

Safety information
Read the Safety Data Sheets (SDSs) and follow the handling instructions. Wear appropriate protective eyewear, clothing, and gloves. Caution: Human origin materials are non-reactive (donor level) for anti-HIV 1 & 2, anti-HCV, and HBsAg. Handle in accordance with established bio-safety practices.

Prepare S-25-Supplemented M-25 Medium

To support the plating and proliferation of human large vessel endothelial cells, including HUVECs, supplement M-25 Medium with S-25 (included in the kit). S-25 is an endothelial supplement that has
been optimized for angiogenesis applications, improved cell health, and increased growth rates.
1. Thaw the S-25 (50X) solution in a 37°C water bath or overnight at 4°C. If thawed in a water bath, do
not leave the vial at 37°C after the solution has thawed; alternatively, aliquot the S-25 solution and
refreeze only once.
2. Aseptically transfer the contents of the thawed S-25 solution to a bottle containing M-25 Medium at a
ratio of 1:50 (20 µl S-25 supplement/1 ml M-25 Medium). Tightly cap the bottle and swirl to mix. Avoid
causing medium to foam.
3. Thawed S-25 Supplement should be stored in the refrigerator, in the dark, at 4-7°C, and used within 3
weeks.
4. Prepare supplemented medium as needed and use immediately, and store unused S-25-
supplemented medium in the dark at 4-7°C. Do not freeze supplemented medium. When stored
properly, S-25-supplemented M-25 Medium is stable for up to 3 weeks.

Tube Formation Assay

Note: For the option of expedient micro-vessel induction use an Inductive Niche Module (INM), check INSTRUCTION: INM-5-24.

The following procedure was designed for the seeding of cells onto a 24-well plate. Please note that the 4 wells in column 1 (A1 to D1) are not coated with SMS-ECM-1 and can serve as control wells if needed.
1. Remove the plate from the freezer and allow the plate to come to room temperature for 30-40 min.
2. Carefully remove the plastic cover inside of a class 2 biosafety hood.
3. Equilibrate a sufficient volume of M-25 medium without the S-25 supplement to wash the coated wells by incubating the unsupplemented M-25 medium at 37°C in humidified atmosphere containing 5%
CO2. Use approximately 35 ml M-25 medium for each 24-well plate, or 1.5 ml for each of the 20 coated wells.
4. Equilibrate a sufficient volume of M-25 medium with the S-25 supplement (+ antibiotics) by incubating the S-25-supplemented M-25 medium at 37 C° in the humidified atmosphere of 5% CO2. Use
approximately 13 ml S-25-supplemented M-25 medium for each 24-well plate, or 0.5 ml for each of the 20 coated wells.
5. Wash the wells three times with 0.5 ml equilibrated, unsupplemented M-25 medium. Do not touch the bottom of the plate with the vacuum tip. Instead, you may tilt the plate and remove excess fluid
from the side.
6. Add 0.5 ml equilibrated S-25-supplemented M-25 medium (+ antibiotics) to each well.
7. Incubate the 24-well plate at 37°C in a humidified atmosphere containing 5% CO2. The plate is now ready for the plating of HUVECs.

Plating HUVECs
1. Rapidly thaw cryopreserved HUVECs (0.5ml; >500k) in a 37°C water bath. Please ensure that the tube is incubated for less than 90 seconds and that the cell suspension is only marginally thawed. After 90
seconds in the water bath, mix the HUVECs and continue to thaw them gently at room temperature.
2. Use 20 µl of the suspension to determine the amount and viability of the cells.
3. Add 20-40 µl of the cell suspension to each well (>1000 k cells/ml; 5-10 k cells/cm2 per well).
4. Cover the plate, and gently shake horizontally to disperse the cells within the well.

Incubating the 24-well plate
1. Incubate the 24-well plate at 37 °C in a humidified atmosphere containing 5% CO2.
2. The following day, replace the medium in each well with 0.5 ml of fresh supplemented medium (+antibiotics). Do not touch the bottom of the plate with the vacuum tip. Instead, you may tilt the plate
and remove excess fluid from the side.
3. Remove 0.25 ml medium from each well and add 0.5 ml fresh supplemented medium (+ antibiotics) to each well (final volume in each well should be 0.75 ml). Do not touch the bottom of the plate with the
vacuum tip. Instead, you may tilt the plate and remove excess fluid from the side.
4. Remove 0.25 ml medium from each well and add 0.5 ml fresh supplemented medium (+ antibiotics) to each well (final volume in each well should be 1 ml). Do not touch the bottom of the plate with the
vacuum tip. Instead, you may tilt the plate and remove excess fluid from the side.
5. Remove 0.5 ml medium from each well and add 0.5 ml fresh supplemented medium (+ antibiotics) to each well (final volume in each well should be 1 ml). Do not touch the bottom of the plate with the
vacuum tip. Instead, you may tilt the plate and remove excess fluid from the side.
6. Repeat step 5 three times a week (every 2-3 days).

This table applies only to 24-well plates. *The intervals between steps 2 through 5 may be either 2 or 3 days.

Visualization of cells
Cells and tubule can be visualized using fluorescent or non-fluorescent dyes.

Expected results
These expected results apply to HUVECs that are seeded on a 24-well polystyrene plate precoated with SMS-ECM Matrix at 7,000 viable cells/cm2, using S-25-supplemented Medium M-25 and incubated at
37°C in a 5% CO2 atmosphere.
• Day 0: Within 1 hour, most of the HUVECs should be embedded within the matrix and appear as rounded cells.
• Day 1: Cells begin to exhibit a spread shape; some will appear round and be dividing.
• Days 5-10: Cells begin to connect and form a stable microvessel.
• Day 10 (approximately): Cells begin to form a tissue.
• Days 14-21: The tissue remodels dynamically, forming suspended macrovessels; some will be visible to the naked eye. Macrovessels will continue to form, with some remaining stable for
months.

Typically, several suspended macrovessels are formed in each well.

For more details on the expected results, please consult the white paper.

For details on expected results using the Inductive Niche Module option, check instruction INM-5-24 or
white paper (WP INM-5-24).

Limited Product Warranty
SMSbiotech inc. warrants their products as set forth in the SMSbiotechs` General Terms and conditions of Sale found on the website. If you have
any questions, please contact us.

DISCLAIMER: SMSbiotech disclaim all warranties with respect to this document, expressed or implied, including but not limited to those of
merchantability, fitness for a particular purpose, or non-infringement. to the extent allowed by law, in no event shall SMSbiotech be liable,
whether in contract, tort, warranty, or under any statute or on any other basis for special, incidental, indirect, punitive, multiple or
consequential damages in connection with or arising from this document, including but not limited to the use thereof.